Učitavanje...
PHARMACOGENETICS AND PHARMACOGENOMICS OF TARGETED THERAPEUTICS IN CHRONIC MYELOID LEUKEMIA
The advent of targeted therapeutics has greatly improved outcomes of chronic myeloid leukemia (CML) patients. Despite increased efficacy and better clinical responses over cytotoxic chemotherapies, many patients receiving targeted drugs exhibit a poor initial response, develop drug resistance, or un...
Spremljeno u:
| Izdano u: | Mol Diagn Ther |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693681/ https://ncbi.nlm.nih.gov/pubmed/28698977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-017-0292-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|